Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.
Press releases published on August 13, 2025
Applied Therapeutics Reports Second Quarter 2025 Financial Results
- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT- …
Wesdome Reports Second Quarter 2025 Financial Results
TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) today announced its financial results for the three and six months ended June 30, 2025 (“Q2 2025” and “H1 2025”). Preliminary operating …
Aardvark Therapeutics Reports Second Quarter 2025 Financial Results and Provides Pipeline and Business Updates
Compelling new ARD-201 preclinical data informs optimized Phase 2 clinical development strategy of obesity programs: Phase 2 POWER trial of oral ARD-201 to focus on weight rebound in patients discontinuing GLP-1RA therapy, while Phase 2 STRENGTH trial to …
dLocal announces appointment of Chief Financial Officer
MONTEVIDEO, Uruguay, Aug. 13, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a technology - first payments platform, today announced the appointment of Guillermo López Pérez as Chief Financial Officer, who will join …
Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
Reported positive topline data from Phase 1 clinical trial evaluating Company’s second-generation oral norovirus vaccine constructs, supporting potential for improved protection against infection Enrolled approximately 5,000 participants in COVID-19 …
Codexis Reports Second Quarter 2025 Financial Results
Announces revenue of $15.3M vs $14.1M analyst consensus estimate Six presentations featured ECO Synthesis® platform at 2025 TIDES USA annual meeting, including three from leading CDMO collaborators $27.3M raised via ATM facility and Innovatus loan to …
Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update
Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) ALPHA3 Proceeding as a Two-Arm Randomized Trial Comparing Cema-cel After Standard Fludarabine and Cyclophosphamide (FC …
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
ROCKVILLE, MD, Aug. 13, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company developing innovative antibody-based therapeutics for the treatment of cancer, today announced that effective as of August 13, …
Elcora Provides Update on Status of Management Cease Trade Order
HALIFAX, Nova Scotia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM | OTCQB – ECORF), (the "Company" or "Elcora"), is providing this update on the status of a management cease trade order granted on July 30, …
Emerita Announces Upsize to C$25M Brokered Private Placement Financing
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (“Emerita” …
National CACFP Association Reaffirms Commitment to Adult Day Care Providers
ROUND ROCK, TX, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- The National CACFP Association (NCA) is proud to reaffirm its commitment to supporting adult day care providers who serve older adults and adults with disabilities through the Child and …
LYNO AI Reports Strong Momentum in Early Bird Presale Ahead of Price Increase to $0.055
ROAD TOWN, British Virgin Islands, Aug. 13, 2025 (GLOBE NEWSWIRE) -- LYNO AI is progressing at a rapid pace during its Early Bird presale period, attracting attention from traders and investors. The project’s autonomous AI-powered cross-chain arbitrage …
Dundee Precious Metals Announces Overwhelming Shareholder Approval for Acquisition of Adriatic Metals and Name Change
TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM”) is pleased to announce the voting results from its special meeting (the “Meeting”) of DPM shareholders (“Shareholders”) held at 10:00 a.m. (Toronto time) on August 13 …
Terra Balcanica Closes Fully Subscribed LIFE Offering
Vancouver, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) is pleased to announce the closing of the second and final tranche of its non-brokered, listed issuer financing …
LYNO AI Approaches Early Bird Allocation Threshold as Demand Grows
ROAD TOWN, British Virgin Islands, Aug. 13, 2025 (GLOBE NEWSWIRE) -- LYNO AI is fast approaching its Early Bird cap as the AI-powered cross-chain arbitrage token continues to gain momentum. The presale phase offers LYNO tokens at $0.050 per token with 16 …
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on regenerative and immune cellular therapies, today announced that the U.S. Food and Drug Administration ( …
LYNO AI Early Bird Presale Gains Momentum as Participation Levels Rise
ROAD TOWN, British Virgin Islands, Aug. 13, 2025 (GLOBE NEWSWIRE) -- LYNO AI, a cross-chain arbitrage protocol powered by artificial intelligence, has reported strong traction during its Early Bird presale phase, with more than 260,000 tokens already sold. …
24/7 Market News: LIXTE Biotechnology Holdings Embraces Cryptocurrency in Corporate Treasury Strategy
DENVER, Aug. 13, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, reports that LIXTE Biotechnology Holdings (Nasdaq: LIXT), a clinical-stage …
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases …